Gastric electrical stimulation (the Enterra device) is FDA-approved under humanitarian device exemption but shows mixed results in clinical trials (McCallum et al., Gastroenterology, 2010)
Osteoporos Int 2005
Blind subacromial injection via the posterior approach Blind injections however are not a 100% accurate and studies have shown that the accuracy is 76% via the posterior approach, 69% via anteromedial approaches (Henkus, 2006)
Health care professionals and patients are encouraged to report adverse events or side effects related to the use of this product to FDA's MedWatch Safety Information and Adverse Event Reporting Program: Complete and submit the report online MedWatch Online Voluntary Reporting Form, or Download and complete the form, then submit it via fax at 1-800-FDA-0178
Remember, not all treatments are suitable for everyone
Heres what it can do for your research: Dissolves Peptides Bacteriostatic Water is used to reconstitute dry peptides to a liquid form, making it easier to measure and use